EAF1
From Wikipedia, the free encyclopedia
|
ELL associated factor 1
|
|||||||||||
| Identifiers | |||||||||||
| Symbol(s) | EAF1; | ||||||||||
| External IDs | OMIM: 608315 MGI: 1921677 HomoloGene: 12561 | ||||||||||
|
|||||||||||
| RNA expression pattern | |||||||||||
| Orthologs | |||||||||||
| Human | Mouse | ||||||||||
| Entrez | 85403 | 74427 | |||||||||
| Ensembl | ENSG00000144597 | ENSMUSG00000021890 | |||||||||
| Uniprot | Q96JC9 | Q9D4C5 | |||||||||
| Refseq | NM_033083 (mRNA) NP_149074 (protein) |
NM_028932 (mRNA) NP_083208 (protein) |
|||||||||
| Location | Chr 3: 15.44 - 15.46 Mb | Chr 14: 30.32 - 30.34 Mb | |||||||||
| Pubmed search | [1] | [2] | |||||||||
ELL associated factor 1, also known as EAF1, is a human gene.[1]
[edit] References
[edit] Further reading
- Simone F, Polak PE, Kaberlein JJ, et al. (2001). "EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein.". Blood 98 (1): 201–9. PMID 11418481.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:. PMID 12477932.
- Polak PE, Simone F, Kaberlein JJ, et al. (2003). "ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL leukemia.". Mol. Biol. Cell 14 (4): 1517–28. doi:. PMID 12686606.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:. PMID 14702039.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:. PMID 15489334.
- Kong SE, Banks CA, Shilatifard A, et al. (2005). "ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELL.". Proc. Natl. Acad. Sci. U.S.A. 102 (29): 10094–8. doi:. PMID 16006523.
- Xiao W, Jiang F, Wang Z (2006). "ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation.". Prostate 66 (1): 1–12. doi:. PMID 16114057.
- Olsen JV, Blagoev B, Gnad F, et al. (2006). "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.". Cell 127 (3): 635–48. doi:. PMID 17081983.
- Jiang F, Ai J, Xiao W, Wang Z (2007). "FB1, an E2A fusion partner in childhood leukemia, interacts with U19/EAF2 and inhibits its transcriptional activity.". Cancer Lett. 253 (2): 265–72. doi:. PMID 17395368.

